what are the glp-1 agonists Evolution of GLP‐1 Receptor for Diabetes Treatment A schematic overview of GLP-1

Indeed, there is growing interest in the potential of new classes of anti-diabetic medications such as glucagon-like peptide-1 receptor (GLP-1R) agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors, to reduce the risk of cardiovascular events and slow down the progression of neuronal damage

This prevents any single area from developing irritation, scar tissue, or lipodystrophy (a breakdown of fat tissue)

pylori infection in China or Turkey (121, 122)

The drugs have shown remarkable efficacy in treating obesity in addition to their utility in controlling Type 2 diabetes

Brzoska T, Luger TA, Maaser C, Abels C, Bohm M